ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026
Safety and efficacy of a suction cervical stabilizer for IUD insertion: Results from a multicenter post-marketing study.
Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveTo evaluate the experiences with an atraumatic device (Carevix®) for intrauterine device (IUD) placement in routine clinical practice.
methodsOur prospective, post-marketing study was conducted in 19 centers in Europe, Brazil and the USA. IUD insertions using Carevix device were documented for completion rates, patient-reported pain scores, cervical bleeding, and operator and patient satisfaction. Demographics, uterine position, and menstrual cycle phase were also recorded.
resultsA total of 1123 IUD placements were analyzed. Most participants (819/992; 83%) were 18-40 years old; 46% (513/1123) were nulliparous and 47% (526/1123) were menstruating at the time of the procedure. The procedure was completed with Carevix alone in 82% (925/1123) of participants. Additional tenaculum use was mostly due to spontaneous vacuum loss (194/1123). Completion rates without a tenaculum were lower in nulliparous than in parous women (78% versus 86%). Average visual analog pain scores were lower with Carevix alone (35 ± 21) than when a tenaculum was required (43 ± 21). Most participants (73%) reported less pain than expected, and only 3% reported more pain. Among providers, 82% were satisfied with Carevix, citing ease of use, visibility, and low patient discomfort.
conclusionsIn a multicenter real-world setting, the novel, atraumatic device demonstrated feasibility and safety, with high completion rates and high satisfaction among both operators and patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.